Indication
Weight Gain
12 clinical trials
18 products
1 drug
Clinical trial
A Phase 1, Open-Label, Fixed-Sequence Crossover Study to Evaluate the Effect of a Strong Inhibitor of Cytochrome P450 2C19 on the Pharmacokinetics of Miricorilant in Healthy SubjectsStatus: Completed, Estimated PCD: 2023-02-23
Product
MiricorilantProduct
FluvoxamineClinical trial
A Phase 2 Open Label Study to Evaluate the Safety, Tolerability, and Efficacy of ARD-101 in Subjects At Least One Year After Bariatric SurgeryStatus: Completed, Estimated PCD: 2023-02-03
Product
ARD-101Clinical trial
Niacin Regulation of Regional Adipose Tissue LipolysisStatus: Recruiting, Estimated PCD: 2027-05-31
Product
NiacinClinical trial
Semaglutide 2.4mg for Low Responders After Bariatric SurgeryStatus: Not yet recruiting, Estimated PCD: 2026-02-01
Product
SemaglutideClinical trial
Role Of Metabolic Adaptation In Weight Regain: Expend Follow-UpStatus: Completed, Estimated PCD: 2024-05-24
Product
TirzepatideClinical trial
Bioenergetic and Metabolic Consequences of the Loss of Ovarian Function in Women - 2018Status: Recruiting, Estimated PCD: 2024-08-31
Product
GnRH antagonistProduct
EstrogenProduct
EstradiolProduct
Placebo GnRH antagonistClinical trial
A Phase III/IV Factorial Randomized Double-blind Trial to Compare the Addition of Dapagliflozin vs Placebo and Rosuvastatin/Ezetimibe Versus Pitavastatin in Patients With HIV on Integrase Strand Transfer Inhibitor-based Antiretrovirals With Elevated Metabolic RiskStatus: Not yet recruiting, Estimated PCD: 2025-07-01
Product
DapagliflozinProduct
PitavastatinProduct
Rosuvastatin + EzetimibeDrug
VarlilumabClinical trial
A Phase 2 Randomized Cross-Over Design Study of the Early Metabolic Effects of Dolutegravir or Tenofovir Alafenamide in Healthy VolunteersStatus: Not yet recruiting, Estimated PCD: 2028-01-31
Product
Tenofovir alafenamideProduct
DolutegravirClinical trial
Explorations Into the Mechanism for INSTI-associated Weight Gain: a Focus on Energy BalanceStatus: Completed, Estimated PCD: 2023-01-25
Product
DoravirineClinical trial
Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo- Controlled Trial (SURMOUNT-ADOLESCENTS-2)Status: Not yet recruiting, Estimated PCD: 2027-05-01
Clinical trial
Can the Weight Gain Associated With Use of Integrase Strand Inhibitors be Halted or Reversed With a Switch to Doravirine/Lamivudine/Tenofovir DF in Patients Living With HIV? (DeLiTE)Status: Terminated, Estimated PCD: 2024-03-31
Product
DOR/3TC/TDFClinical trial
Pragmatic Trial Comparing Weight Gain in Children With Autism Taking Risperidone Versus AripiprazoleStatus: Recruiting, Estimated PCD: 2024-07-01